Loading...
Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
BACKGROUND: β-amyloid (Aβ) positron emission tomography (PET) imaging is currently the only Food and Drug Administration-approved method to support clinical diagnosis of Alzheimer’s disease (AD). However, numerous research studies support the use of cerebrospinal fluid (CSF) biomarkers, as a cost-ef...
Na minha lista:
| Udgivet i: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7110644/ https://ncbi.nlm.nih.gov/pubmed/32234072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00595-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|